On December 7, KimForest (Stock Code: 6645.TWO) and its subsidiary Essense AI hosted a forum to champion the future of precision health management. During the event, Essense AI's General Manager, Daniel Huang, proudly announced the operation of the Whole Genome AI Platform, set to go live in Q1 next year.

This innovative platform integrates physician expertise with AI, simplifying complex genetic test results into clear, actionable health insights. By empowering healthcare professionals and educating patients, the platform aims to make precision health accessible to all and ensure fairness and inclusivity in precision healthcare, emphasized by KimForest President Jessica Chen.

A new era of health management begins now!

Learn more:
https://news.gbimonthly.com/tw/article/show.php?num=73161
#AIinHealthcare #PrecisionHealth #Genomics #Globalbio


Jessica Chen, President at KimForest (Photo by Lydia Lee)
 
Daniel Huang, General Manager at Essense AI (Photo by Lydia Lee)
 
(Reporter Alice Peng)